Penumbra (PEN) Total Current Liabilities (2014 - 2026)
Penumbra (PEN) reported Total Current Liabilities of $211.7 million for Q1 2026, up 33.47% year-over-year from $158.6 million in Q1 2025, and up 15.62% quarter-over-quarter from $183.1 million in Q4 2025.
Penumbra (PEN) Total Current Liabilities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Total Current Liabilities data on file, last reported at $211.7 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $211.7 million, up 33.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $211.7 million (up 33.47% YoY), and the FY2025 annual result was $183.1 million, up 15.65% from the prior year.
- Total Current Liabilities grew to $211.7 million in Q1 2026 per PEN's latest filing, from $183.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $211.7 million in Q1 2026 and troughed at $130.1 million in Q1 2022.
- A 5-year average of $155.4 million and a median of $151.1 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities decreased 1.02% in 2023, then jumped 33.47% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $144.9 million in 2022, then rose by 4.29% to $151.1 million in 2023, then gained by 4.76% to $158.3 million in 2024, then rose by 15.65% to $183.1 million in 2025, then rose by 15.62% to $211.7 million in 2026.
- Business Quant data shows PEN's Total Current Liabilities at $211.7 million in Q1 2026, $183.1 million in Q4 2025, and $169.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 1.41 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.53 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.22 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 211.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.73 Mn |
| Dec 31, 2025 | 183.13 Mn |
| Sep 30, 2025 | 169.60 Mn |
| Jun 30, 2025 | 157.76 Mn |
| Mar 31, 2025 | 158.63 Mn |
| Dec 31, 2024 | 158.35 Mn |
| Sep 30, 2024 | 153.19 Mn |
| Jun 30, 2024 | 150.99 Mn |
| Mar 31, 2024 | 152.80 Mn |
| Dec 31, 2023 | 151.14 Mn |
| Sep 30, 2023 | 145.08 Mn |
| Jun 30, 2023 | 144.12 Mn |
| Mar 31, 2023 | 146.33 Mn |
| Dec 31, 2022 | 144.93 Mn |
| Sep 30, 2022 | 138.33 Mn |
| Jun 30, 2022 | 145.60 Mn |
| Mar 31, 2022 | 130.10 Mn |
| Dec 31, 2021 | 123.20 Mn |
| Sep 30, 2021 | 116.06 Mn |
| Mar 31, 2021 | 111.86 Mn |